alcmi.bsky.social
The Addario Lung Cancer Medical Institute (ALCMI) is a non-profit international consortium comprised of over 25 of the world's premier oncology research institutions. We fund and support investigator-led lung cancer clinical trials.
👤 Joined on 13 January 2025
Followers
Following
Total Posts
@alcmi.bsky.socialLung cancer is the leading cause of cancer-related mortality worldwide, causing approximately 1.8 million deaths in 2022 📝 very good review that discusses epidemiology, dx, tx & prognosis of #lungcancer in nonsmokers. @alcmi.bsky.social @laurengroner.bsky.social jamanetwork.com/journals/jam...
Show Post“CyPath® Lung gave us the clarity we needed to act early,” said Dr. Gordon Downie, CMO, referring to a Stage 1A mucinous adenocarcinoma missed by other diagnostics. Every early diagnosis is a life potentially saved. Read the press release: bit.ly/4l6uOvn #CyPathLung #LungCancer #bioAffinity
Show PostJoin the IASLC 2025 ASCO Highlights webinar on June 27 for expert insights into the latest breakthroughs in lung cancer treatment. 👉 Register now: bit.ly/4n93NKk #IASLC #ASCO2025 #LungCancer #Oncology #CancerResearch #ThoracicOncology #MedicalEducation @ascocancer.bsky.social
Show PostEQUAL Study Launches Lung Cancer Screening Trial for People at High Risk @narjustflorezmd.bsky.social @danafarber.bsky.social oncodaily.com/insight/lung... #OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #EQUAL #LungCancer
Show Post